Skip to main content

Marijuana Industry Equity Advocates Aim To Shape Northeast Governors Legalization Talks

The House of Representatives approved a bill last week to protect banks that service marijuana businesses. But remarkable as it was to see the first standalone piece of cannabis reform legislation clear the chamber, perhaps even more impressive was the extent to which it garnered bipartisan support.

Every single Democratic present on the floor except one (229 members) voted in favor of the Secure and Fair Enforcement (SAFE) Banking Act, sponsored by Rep. Ed Perlmutter (D-CO). And nearly half of all Republicans (91 members) joined them. While advocates anticipated that it would pass, the final tally, 321-103, exceeded many expectations.

2019 marijuana banking bill vote, via GovTrack.

What changed since the last time Congress voted on cannabis banking?

This was a first-of-its kind vote on standalone marijuana legislation in the chamber. But a useful comparison comes from 2014, when the House voted on a similar but more limited appropriations amendment aimed at preventing the Treasury Department from penalizing banks that service cannabis businesses.

That measure passed 231-192 (though it was not enacted into law after the Senate declined to consider the provision). Among Democrats, 186 approved the earlier amendment, while 12 opposed it. About half as many Republicans voted for the 2014 amendment (45 members) than supported the SAFE Banking Act last week, while 180 voted against it.

In other words, Democratic support for a marijuana banking fix increased by 43 votes, or 21 percent, from 2014 to 2019. Republican support grew by 46 votes, or 68 percent, during that time period.

2014 marijuana banking amendment vote, via GovTrack.

Among those present for both votes (235 members), here’s who flipped from “no” to “yes”: 

  • Rep. Andy Barr (R-KY)
  • Rep. Rob Bishop (R-UT)
  • Rep. Mo Brooks (R-AL)
  • Rep. Tom Cole (R-OK)
  • Rep. Doug Collins (R-GA)
  • Rep. Henry Cuellar (D-TX)
  • Rep. Charles Fleischmann (R-TN)
  • Rep. Bill Flores (R-TX)
  • Rep. Bob Gibbs (R-OH)
  • Rep. Tom Graves (R-GA)
  • Rep. Morgan Griffith (R-VA)
  • Rep. Jaime Herrera Beutler (R-WA)
  • Rep. Bill Johnson (R-OH)
  • Rep. William Keating (D-MA)
  • Rep. Mike Kelly (R-PA)
  • Rep. Adam Kinzinger (R-IL)
  • Rep. Daniel Lipinski (D-IL)
  • Rep. Billy Long (R-MO)
  • Rep. Kevin McCarthy (R-CA)
  • Rep. David McKinley (R-WV)
  • Rep. Cathy McMorris Rodgers (R-WA)
  • Rep. Devin Nunes (R-CA)
  • Rep. Pete Olson (R-TX)
  • Rep. Scott Perry (R-PA)
  • Rep. Collin Peterson (D-MN)
  • Rep. Tom Reed (R-NY)
  • Rep. Phil Roe (R-TN)
  • Rep. Mike Rogers (R-AL)
  • Rep. Linda Sánchez (D-CA)
  • Rep. Mike Simpson (R-ID)
  • Rep. Steve Stivers (R-OH)
  • Rep. Glenn Thompson (R-PA)
  • Rep. Scott Tipton (R-CO)
  • Rep. Greg Walden (R-OR)
  • Rep. Debbie Wasserman Schultz (D-FL)
  • Rep. Steve Womack (R-AR)
  • Rep. Ted Yoho (R-FL)

And “yes” to “no”: 

  • Rep. Larry Bucshon (R-IN)
  • Rep. Chris Stewart (R-UT)

All told, 44 members voted differently this year as compared to 2014, including 37 who flipped from “no” to “yes” and two who went in the other direction. Two lawmakers who previously voted “yes”—Reps. Elijah Cummings (D-MD) and Jim Clyburn (D-SC)—were absent for this latest vote. One former “no” vote, Rep. Rick Crawford (R-AR), was absent for this vote. And finally, two members who were absent in 2014 voted “no” this round, Reps. Scott DesJarlais (R-TN) and Bradley Byrne (R-AL).

State marijuana action matters.

While support for letting banks service marijuana businesses isn’t necessarily indicative of support for legalization itself, it’s clear that the bill would benefit legal states, and Republican votes in favor of the legislation were significantly higher among those representing such states. Of GOP members representing states with either full adult-use or comprehensive medical cannabis programs, 41 opposed the SAFE Banking Act.

(The following analysis doesn’t include those states allowing CBD only.)

GOP members who voted “no” representing legal states: 

  • Rep. Jack Bergman (R-MI)
  • Rep. Andy Biggs (R-AZ)
  • Rep. Gus Bilirakis (R-FL)
  • Rep. Vern Buchanan (R-FL)
  • Rep. Ken Buck (R-CO)
  • Rep. Ken Calvert (R-CA)
  • Rep. Steve Chabot (R-OH)
  • Rep. Paul Cook (R-CA)
  • Rep. Mario Diaz-Balart (R-FL)
  • Rep. Neal Dunn (R-FL)
  • Rep. Jim Jordan (R-OH)
  • Rep. Greg Gianforte (R-MT)
  • Rep. Paul Gosar (R-AZ)
  • Rep. Garret Graves (R-LA)
  • Rep. Sam Graves (R-MO)
  • Rep. Andy Harris (R-MD)
  • Rep. Vicky Hartzler (R-MO)
  • Rep. Bill Huizenga (R-MI)
  • Rep. Mike Johnson (R-LA)
  • Rep. John Joyce (R-PA)
  • Rep. Darin LaHood (R-IL)
  • Rep. Doug LaMalfa (R-CA)
  • Rep. Doug Lamborn (R-CO)
  • Rep. Robert Latta (R-OH)
  • Rep. Debbie Lesko (R-AZ)
  • Rep. Frank Lucas (R-OK)
  • Rep. John Moolenaar (R-MI)
  • Rep. Markwayne Mullin (R-OK)
  • Rep. Bill Posey (R-FL)
  • Rep. John Rutherford (R-FL)
  • Rep. Steve Scalise (R-LA)
  • Rep. John Shimkus (R-IL)
  • Rep. Christopher Smith (R-NJ)
  • Rep. Jason Smith (R-MO)
  •  Rep. Chris Stewart (R-UT)
  • Rep. Michael Turner (R-OH)
  • Rep. Ann Wagner (R-MO)
  • Rep. Tim Walberg (R-MI)
  • Rep. Daniel Webster (R-FL)
  • Rep. Brad Wenstrup (R-OH)
  • Rep. Bruce Westerman (R-AR)

2019 marijuana banking bill vote, via GovTrack.

Though it’s not clear from this vote which members might be inclined to extend their support for modest marijuana banking reform to broader policy changes such as descheduling, those who voted “no” would in all likelihood not be supportive of comprehensive reform at this point.

Noteworthy votes.

It was easy to find the outlier among Democrats, as only one member defected and opposed the bill: Rep. Terri Sewell (D-AL), whose office did not respond to a request for comment about why the congresswoman voted against the legislation.

But there were also some notable votes in favor of the SAFE Banking Act that came from Republican leadership in the House.

The highest ranking Republican in the House, Minority Leader McCarthy, voted in favor of the bill, while the rest of the party’s leadership—Minority Whip Steve Scalise (R-LA), Republican Conference Chair Liz Cheney (R-WY) and Policy Committee Chair Gary Palmer (R-AL)—voted no. (McCarthy is the only one of the bunch representing a state with a legal cannabis market.)

Collins, ranking member of the Judiciary Committee, which plays a key role in shaping federal drug laws, changed his vote to “yes” after having been opposed to the 2014 amendment.

Stivers, an original cosponsor of the SAFE Banking Act who voted in favor of it on Wednesday, voted against the previous amendment with the narrower scope.

Barr of Kentucky flipped to a “yes” even after voting against the measure in the House Financial Services Committee earlier this year. It’s likely that a last-minute amendment clarifying that the banking protections also apply to hemp and CBD businesses was a factor in his decision.

Griffith, Perry and Roe each voted “yes” this round, possibly related to their more recent involvement in medical cannabis-related legislation.

Two Democrats who voted against the banking amendment in 2014 and who are now facing primary challenges from progressive opponents—Lipinski and Cuellar—opted to approve the SAFE Banking Act this time.

Finally, Wasserman Schultz, who has stood out among Democrats in her longstanding opposition to marijuana reform even as a former chair of the party, voted in favor of the bill on Wednesday.

Wednesday’s vote is the latest example of waning support for the status quo of prohibition in the most marijuana friendly Congress in history.

Though not a vote on ending federal prohibition, the banking legislation represented what many advocates regard as the first step toward legalization, and the result proved promising for the prospects of broader reform. It’s less clear how the bill will fare in the Republican-controlled Senate, which officially received the SAFE Banking Act from the House on Friday, but the largely bipartisan nature of the vote could help push it forward in the other chamber.

Senate Banking Committee Chairman Mike Crapo (R-ID), whose panel already held a hearing on the issue earlier this year, said he wants to have a vote on cannabis banking legislation by the end of the year—a notable evolution from his previous criticism of advancing such a reform while marijuana remains federally illegal.

“The fact that it got nearly 100 percent of Dems and pretty close to 50 percent of Republican demonstrates how mainstream cannabis reform has come,” Michael Liszewski, senior regulatory affairs counsel at 4Front Ventures, told Marijuana Moment. “Even [Reps. Henry Cuellar (D-TX) and Debbie Wasserman Schultz (D-FL)] couldn’t vote against. The fact that so many Republicans supported it shows that it can be successful in the Senate.”

“I won’t pretend to assume that we have a proportionate level of support for SAFE in the Senate, but even with a reasonable drop off, we can get to 60,” he said. “And now we can encourage all of the Republicans who voted in favor of SAFE to urge the senators from their states to cosponsor SAFE.”

Senate Committee Declines To Expand State Marijuana Protections In Spending Bill

Photo courtesy of Brian Shamblen.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Original Article Source: https://www.marijuanamoment.net/marijuana-industry-equity-advocates-aim-to-shape-northeast-governors-legalization-talks/

Comments

Post a Comment

Popular posts from this blog

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs
Post a Comment
Read more

Charlotte Figi The Girl Who Inspired A CBD Movement Has Died At Age 13

Charlotte had recently been hospitalized due to pneumonia, breathing problems and seizures. She was treated as a likely case of Covid-19, her mother, Paige Figi, said Wednesday, although she tested negative for the virus. “Charlotte is no longer suffering. She is seizure-free forever,” a family friend wrote on Paige Figi’s Facebook page, announcing Charlotte’s death. “Thank you so much for all of your love.” Charlotte became a symbol of the possibilities of CBD after CNN Chief Medical Correspondent Dr. Sanjay Gupta told her story in the documentary “Weed.” In the film, Charlotte was shown to be a playful child who was overcome by horrific seizures, which were quelled with Charlotte’s Web, a marijuana strain named in her honor. Charlotte had Dravet syndrome, a rare form of epilepsy which was not controlled by medication. The Stanley brothers, marijuana growers in Colorado, were crossbreeding a strain of marijuana high in CBD and low in THC, its psychoactive ingredient. After Charlo
Post a Comment
Read more

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multistate
Post a Comment
Read more